Research Article
BibTex RIS Cite
Year 2022, Volume: 5 Issue: 1, 257 - 261, 17.01.2022
https://doi.org/10.32322/jhsm.1011444

Abstract

References

  • Srinivasan R. Ablation of polymers and biological tissue by ultraviolet lasers. Science (New York, NY). 1986; 234: 559-65.
  • Chen S, Feng Y, Stojanovic A, Jankov MR, 2nd, Wang Q. IntraLase femtosecond laser vs mechanical microkeratomes in LASIK for myopia: a systematic review and meta-analysis. J Refract Surg (Thorofare, NJ : 1995) 2012; 28: 15-24.
  • Kymionis GD, Kankariya VP, Plaka AD, Reinstein DZ. Femtosecond laser technology in corneal refractive surgery: a review. J Refract Surg (Thorofare, NJ: 1995) 2012; 28: 912-20.
  • Shortt AJ, Bunce C, Allan BD. Evidence for superior efficacy and safety of LASIK over photorefractive keratectomy for correction of myopia. Ophthalmology 2006; 113: 1897-908.
  • Majmudar PA, Forstot SL, Dennis RF, et al. Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology 2000; 107: 89-94.
  • Miraftab M, Hashemi H, Asgari S. Matched optical quality comparison of 3-year results of PRK-MMC and phakic IOL implantation in the correction of high myopia. Eye (London, England) 2015; 29: 926-31.
  • Hashemi H, Miraftab M, Asgari S. Comparison of the visual outcomes between PRK-MMC and phakic IOL implantation in high myopic patients. Eye (London, England) 2014; 28: 1113-8.
  • Rajan MS, Jaycock P, O'Brart D, Nystrom HH, Marshall J. A long-term study of photorefractive keratectomy; 12-year follow-up. Ophthalmology 2004; 111: 1813-24.
  • Castro-Luna G, Jimenez-Rodriguez D, Perez-Rueda A, Alaskar-Alani H. Long Term Follow-Up Safety and Effectiveness of Myopia Refractive Surgery. Int J Environ Res Public Health 2020; 17.
  • Taneri S, Knepper J, Rost A, Dick HB. [Long-term outcomes of PRK, LASIK and SMILE]. Ophthalmologe 2021.
  • Steinert RF, Hersh PS. Spherical and aspherical photorefractive keratectomy and laser in-situ keratomileusis for moderate to high myopia: two prospective, randomized clinical trials. Summit technology PRK-LASIK study group. Trans Am Ophthalmol Soc 1998; 96: 197-221.
  • Hersh PS, Brint SF, Maloney RK, et al. Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia. A randomized prospective study. Ophthalmology. 1998; 105: 1512-22.
  • Alió JL, Ortiz D, Muftuoglu O, Garcia MJ. Ten years after photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) for moderate to high myopia (control-matched study). Br J Ophthalmol 2009; 93: 1313-8.
  • Pallikaris IG, Siganos DS. Excimer laser in situ keratomileusis and photorefractive keratectomy for correction of high myopia. J Refract Corneal Surg 1994; 10: 498-510.
  • Wallau AD, Campos M. Photorefractive keratectomy with mitomycin C versus LASIK in custom surgeries for myopia: a bilateral prospective randomized clinical trial. J Refract Surg (Thorofare, NJ : 1995) 2008; 24: 326-36.
  • Ghadhfan F, Al-Rajhi A, Wagoner MD. Laser in situ keratomileusis versus surface ablation: visual outcomes and complications. J Cataract Refract Surg 2007; 33: 2041-8.
  • Aslanides IM, Georgoudis PN, Selimis VD, Mukherjee AN. Single-step transepithelial ASLA (SCHWIND) with mitomycin-C for the correction of high myopia: long term follow-up. Clin Ophthalmol (Auckland, NZ) 2015; 9: 33-41.
  • Van Gelder RN, Steger-May K, Yang SH, Rattanatam T, Pepose JS. Comparison of photorefractive keratectomy, astigmatic PRK, laser in situ keratomileusis, and astigmatic LASIK in the treatment of myopia. J Cataract Refract Surg 2002; 28: 462-76.
  • Chhadva P, Cabot F, Galor A, Karp CL, Yoo SH. Long-term outcomes of flap amputation After LASIK. J Refract Surg (Thorofare, NJ: 1995) 2016; 32: 136-7.
  • Zhao W, Zhang Y. Comparison and predictive factors analysis for efficacy and safety of Kirschner wire, anatomical plate fixation and cannulated screw in treating patients with open calcaneal fractures. Medicine 2019; 98: e17498.

Comparison of visual and refractive outcomes between femtosecond laser-assisted in situ keratomileusis (FS-LASIK) and photorefractive keratectomy (PRK): a long-term outcomes analysis

Year 2022, Volume: 5 Issue: 1, 257 - 261, 17.01.2022
https://doi.org/10.32322/jhsm.1011444

Abstract

Aim: We aimed to compare the results of photorefractive keratectomy (PRK) and femtosecond-assisted laser in situ keratomileusis (FS-LASIK) procedures in the treatment of myopia and myopic astigmatism.
Material and Method: Seventy eyes of 35 patients with myopia and/or myopic astigmatism who had undergone PRK procedure were compared retrospectively with 70 eyes of 35 patients with myopia and/or myopic astigmatism who had undergone FS-LASIK procedure.
Results: All patients completed the 2-year follow-up period. With respect to age and sex, PRK and FS-LASIK groups were comparable. The differences in uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and spherical equivalent were significantly better with PRK than with FS-LASIK at 6- and 24-month visits. FS-LASIK and PRK had similar values of safety index, efficacy index, and predictability at 6 and 24 months postoperatively. No significant complications were observed in neither of the procedures during the follow-up period.
Conclusion: Both PRK and FS-LASIK seem equally effective options for the correction of myopia and myopic astigmatism. However, PRK provided slightly better visual and refractive outcomes than FS-LASIK at 6 and 24 months postoperatively.

References

  • Srinivasan R. Ablation of polymers and biological tissue by ultraviolet lasers. Science (New York, NY). 1986; 234: 559-65.
  • Chen S, Feng Y, Stojanovic A, Jankov MR, 2nd, Wang Q. IntraLase femtosecond laser vs mechanical microkeratomes in LASIK for myopia: a systematic review and meta-analysis. J Refract Surg (Thorofare, NJ : 1995) 2012; 28: 15-24.
  • Kymionis GD, Kankariya VP, Plaka AD, Reinstein DZ. Femtosecond laser technology in corneal refractive surgery: a review. J Refract Surg (Thorofare, NJ: 1995) 2012; 28: 912-20.
  • Shortt AJ, Bunce C, Allan BD. Evidence for superior efficacy and safety of LASIK over photorefractive keratectomy for correction of myopia. Ophthalmology 2006; 113: 1897-908.
  • Majmudar PA, Forstot SL, Dennis RF, et al. Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology 2000; 107: 89-94.
  • Miraftab M, Hashemi H, Asgari S. Matched optical quality comparison of 3-year results of PRK-MMC and phakic IOL implantation in the correction of high myopia. Eye (London, England) 2015; 29: 926-31.
  • Hashemi H, Miraftab M, Asgari S. Comparison of the visual outcomes between PRK-MMC and phakic IOL implantation in high myopic patients. Eye (London, England) 2014; 28: 1113-8.
  • Rajan MS, Jaycock P, O'Brart D, Nystrom HH, Marshall J. A long-term study of photorefractive keratectomy; 12-year follow-up. Ophthalmology 2004; 111: 1813-24.
  • Castro-Luna G, Jimenez-Rodriguez D, Perez-Rueda A, Alaskar-Alani H. Long Term Follow-Up Safety and Effectiveness of Myopia Refractive Surgery. Int J Environ Res Public Health 2020; 17.
  • Taneri S, Knepper J, Rost A, Dick HB. [Long-term outcomes of PRK, LASIK and SMILE]. Ophthalmologe 2021.
  • Steinert RF, Hersh PS. Spherical and aspherical photorefractive keratectomy and laser in-situ keratomileusis for moderate to high myopia: two prospective, randomized clinical trials. Summit technology PRK-LASIK study group. Trans Am Ophthalmol Soc 1998; 96: 197-221.
  • Hersh PS, Brint SF, Maloney RK, et al. Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia. A randomized prospective study. Ophthalmology. 1998; 105: 1512-22.
  • Alió JL, Ortiz D, Muftuoglu O, Garcia MJ. Ten years after photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) for moderate to high myopia (control-matched study). Br J Ophthalmol 2009; 93: 1313-8.
  • Pallikaris IG, Siganos DS. Excimer laser in situ keratomileusis and photorefractive keratectomy for correction of high myopia. J Refract Corneal Surg 1994; 10: 498-510.
  • Wallau AD, Campos M. Photorefractive keratectomy with mitomycin C versus LASIK in custom surgeries for myopia: a bilateral prospective randomized clinical trial. J Refract Surg (Thorofare, NJ : 1995) 2008; 24: 326-36.
  • Ghadhfan F, Al-Rajhi A, Wagoner MD. Laser in situ keratomileusis versus surface ablation: visual outcomes and complications. J Cataract Refract Surg 2007; 33: 2041-8.
  • Aslanides IM, Georgoudis PN, Selimis VD, Mukherjee AN. Single-step transepithelial ASLA (SCHWIND) with mitomycin-C for the correction of high myopia: long term follow-up. Clin Ophthalmol (Auckland, NZ) 2015; 9: 33-41.
  • Van Gelder RN, Steger-May K, Yang SH, Rattanatam T, Pepose JS. Comparison of photorefractive keratectomy, astigmatic PRK, laser in situ keratomileusis, and astigmatic LASIK in the treatment of myopia. J Cataract Refract Surg 2002; 28: 462-76.
  • Chhadva P, Cabot F, Galor A, Karp CL, Yoo SH. Long-term outcomes of flap amputation After LASIK. J Refract Surg (Thorofare, NJ: 1995) 2016; 32: 136-7.
  • Zhao W, Zhang Y. Comparison and predictive factors analysis for efficacy and safety of Kirschner wire, anatomical plate fixation and cannulated screw in treating patients with open calcaneal fractures. Medicine 2019; 98: e17498.
There are 20 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Original Article
Authors

Mehmet Fatih Karadağ 0000-0001-8679-1605

Publication Date January 17, 2022
Published in Issue Year 2022 Volume: 5 Issue: 1

Cite

AMA Karadağ MF. Comparison of visual and refractive outcomes between femtosecond laser-assisted in situ keratomileusis (FS-LASIK) and photorefractive keratectomy (PRK): a long-term outcomes analysis. J Health Sci Med / JHSM. January 2022;5(1):257-261. doi:10.32322/jhsm.1011444

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912


Editor List for 2022

Assoc. Prof. Alpaslan TANOĞLU (MD)  

Prof. Aydın ÇİFCİ (MD)

Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)

Prof. Murat KEKİLLİ (MD)

Prof. Yavuz BEYAZIT (MD) 

Prof. Ekrem ÜNAL (MD)

Prof. Ahmet EKEN (MD)

Assoc. Prof. Ercan YUVANÇ (MD)

Assoc. Prof. Bekir UÇAN (MD) 

Assoc. Prof. Mehmet Sinan DAL (MD)


Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.